Home › Funds › MAVERICK CAPITAL LTD › RGEN
MAVERICK CAPITAL LTD position in RGEN
REPLIGEN CORP · Health Care
MAVERICK CAPITAL LTD reported holding 1,984,554 shares of RGEN (REPLIGEN CORP) in its Q2 2026 13F filing — a position valued at US$270.8M, representing 2.52% of its reported portfolio and ranking #15 among its reported holdings. MAVERICK CAPITAL LTD has disclosed RGEN holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How MAVERICK CAPITAL LTD's RGEN position evolved
MAVERICK CAPITAL LTD first disclosed a stake in RGEN in Q1 2026 at 1,518,805 shares (US$178.9M). The position peaked in Q2 2026 at 1,984,554 shares, worth US$270.8M. Across 2 filings, MAVERICK CAPITAL LTD increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,984,554 shares valued at US$270.8M — an increase of 465,749 shares quarter over quarter.. Notable position changes include a 31% increase in Q2 2026 (shares rose 41% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 1.52M | $178.95M | New |
| Q2 2026 | 1.98M | $270.77M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About RGEN and 13F data
RGEN (REPLIGEN CORP) is a Health Care company. 32 other funds we track also report a position in RGEN — the largest reported positions include UNITED CAPITAL FINANCIAL ADVISORS, LLC (US$380.8M), Maverick Capital (US$270.8M), CONGRESS ASSET MANAGEMENT CO (US$196.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding RGEN
- UNITED CAPITAL FINANCIAL ADVISORS, LLC 2.79M sh · $380.76M · Q2 2026
- Maverick Capital 1.98M sh · $270.77M · Q2 2026
- CONGRESS ASSET MANAGEMENT CO 1.02M sh · $196.25M · Q3 2026
- WASATCH ADVISORS LP 907.16K sh · $174.38M · Q3 2026
- RTW INVESTMENTS, LP 1.24M sh · $169.27M · Q2 2026
- Conestoga Capital Advisors, LLC 980.98K sh · $133.85M · Q2 2026
- Stephens Investment Management Group LLC 937.08K sh · $127.86M · Q2 2026
- FRED ALGER MANAGEMENT, LLC 733.74K sh · $100.11M · Q2 2026
- DeepCurrents Investment Group LLC 94.44M sh · $96.80M · Q2 2026
- GENEVA CAPITAL MANAGEMENT LLC 656.09K sh · $89.52M · Q2 2026
- Aequim Alternative Investments LP 75.00M sh · $77.09M · Q2 2026
More on MAVERICK CAPITAL LTD
FAQ
How long has MAVERICK CAPITAL LTD held RGEN?
MAVERICK CAPITAL LTD has disclosed RGEN holdings in 2 of the last 2 reported quarters, going back to Q1 2026.
What is MAVERICK CAPITAL LTD's current position in RGEN?
As of Q2 2026, MAVERICK CAPITAL LTD holds 1.98M shares of RGEN (REPLIGEN CORP), valued at $270.77M, representing 2.52% of its reported portfolio and ranking #15.
Has MAVERICK CAPITAL LTD been buying or selling RGEN?
In the latest 13F filing (Q2 2026), MAVERICK CAPITAL LTD increased its position in RGEN. The position peaked in Q2 2026 at 1.98M shares.
Which other funds hold RGEN?
Other major institutional holders of RGEN include UNITED CAPITAL FINANCIAL ADVISORS, LLC, Maverick Capital, CONGRESS ASSET MANAGEMENT CO, among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.